✦ LIBER ✦

P-576 A phase I/II trial of weekly docetaxel and gefitinib in elderlypatients (⩾70) with stage IIIB/IV non-small cell lung cancer (NSCLC)

✍ Scribed by Stinchcombe, T.; Socinski, M.; Choksi, J.; Bakri, K.; Taylor, M.; Tynan, M.; Mears, A.; Smith, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II trial of weekly docetaxel a

✍ Stinchcombe, Thomas E.; Bůžková, Petra; Choksi, Janak; Taylor, Mark; Bakri, Kama 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

52 Milti-institutional phase II trial of

✍ Belani, C.P.; Einzig, A.; Bonomi, P.; Dobbs, T.; Kozak, C.; Cohen, L.; Capozzoli 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Taxol and carboplatin in combination in

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Phase II trial of docetaxel in patients

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 273 KB

A phase II study of docetaxel (taxotere)

✍ Kim, H.K; Lee, K.S; Kim, J.S; Kim, Y.K; Park, H.S; Chung, T.J; Lee, S.N; Kang, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A randomised phase II trial of docetaxel

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB